Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (10.941)

1

enthalten in: Annales de dermatologie et de venereologie | 2019

von Lacour, J.

2

Cardio- and cerebrovascular safety of erenumab, a monoclonal antibody targeting CGRP receptors - important studies on human isolated arteries

enthalten in: Cephalalgia : an international journal of headache | 2019

von Messlinger, K. | MaassenVanDenBrink, A.

3

Durvalumab for the treatment of non-small cell lung cancer

enthalten in: Expert review of anticancer therapy | 2019

von Murakami, S.

4

Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol : a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial

enthalten in: BMJ open | 2019

von Jones, A. | Muller, P. | Dore, C. | +6

5

Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia : A Phase 3, Single-Arm, International Trial

enthalten in: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research | 2019

von Insogna, K. | Rauch, F. | Kamenický, P. | +7

6

The effectiveness of target therapy in patients with severe allergic asthma

enthalten in: Terapevticheskii arkhiv | 2019

von Skorokhodkina, O. | Valeeva, A. | Luntsov, A. | +1

7

Alternative dosing regimens for atezolizumab : right dose, wrong frequency

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Goldstein, D. | Ratain, M.

CommentOn: Cancer Chemother Pharmacol. 2019 Dec;84(6):1257-1267. - PMID 31542806

8

Incorporating isatuximab in the treatment of multiple myeloma

enthalten in: Lancet (London, England) | 2019

von Trudel, S.

CommentOn: Lancet. 2019 Dec 7;394(10214):2096-2107. - PMID 31735560

9

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM) : a randomised, multicentre, open-label, phase 3 study

enthalten in: Lancet (London, England) | 2019

von Attal, M. | Richardson, P. | Rajkumar, S. | +118

CommentIn: Lancet. 2019 Dec 7;394(10214):2045-2047. - PMID 31735559

10

Fatal outcome of atezolizumab in a patient with immune-mediated pneumonitis, thrombocytopenia, and cardiac dysfunction : A case report 

enthalten in: International journal of clinical pharmacology and therapeutics | 2019

von Li, J. | Deng, X. | Wang, B. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1095]